|
 |
 |
 |
New study shows that a cough medicine ingredient could effectively treat prostate cancer
December 19, 2008
Baltimore, MD -- A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60% and limited the spread of tumors by 65% without causing harmful side effects. Prostate cancer is the most common cancer among men in the United States. The American Cancer Society estimates that 186,320 men will be diagnosed with prostate cancer in 2008 and 28,660 will die from it. One man in 6 will get prostate cancer during his lifetime. Although slow-growing in most men, the cancer is considered advanced when it spreads beyond the prostate. There is no known cure. The laboratory study was a joint effort by Dr. Israel Barken of the Prostate Cancer Research and Educational Foundation, Moshe Rogosnitzky of MedInsight Research Institute, and Dr. Jack Geller of The University of California San Diego. Noscapine has previously been studied as a treatment for breast, ovarian, colon, lung and brain cancer and for various lymphomas, chronic lymphocytic leukemia and melanoma. This study, however, is the first to demonstrate its effectiveness in treating prostate cancer. Noscapine is a naturally-occurring substance, a non-addictive derivative of opium. As a natural substance, noscapine cannot be patented, which has limited the potential for clinical trials. Rogosnitzky notes that drug companies are generally unwilling to underwrite expensive clinical trials without being able to recoup their investment. A synthetic derivative of noscapine has been patented but has not yet reached the clinical testing phase. Since noscapine is approved for use in many countries as a cough suppressant, however, it is available to doctors to prescribe for other uses as well. This common practice is known as "off-label" prescription. Noscapine is increasingly being used off-label to treat a variety of cancers. Dr. Barken used noscapine to treat a handful of prostate cancer patients before retiring from clinical practice. Encouraged by the success of these treatments, his foundation funded the laboratory study being reported in the December 2008 edition of Anticancer Research. As founder and medical director of the Prostate Cancer Research and Educational Foundation in San Diego, Dr. Barken is encouraging academic institutions to follow up this successful laboratory research with a human clinical trial. He has pioneered a web-based patient tracking system that will greatly reduce the cost of the trial while cutting the time necessary to complete the study. Using the web-based tracking system will also allow doctors outside the U.S. to enroll patients in the research. Rogosnitzky, director of research at MedInsight Research Institute, points out the significant advantages that noscapine could present as a treatment for prostate cancer. "Noscapine is effective without the unpleasant side effects associated with other common prostate cancer treatments. Because noscapine has been used as a cough-suppressant for nearly half a century, it already has an extensive safety record. This pre-clinical study shows that the dose used to effectively treat prostate cancer in the animal model was also safe." Hormone therapy and chemotherapy, along with radiation and surgery, are currently used to slow the progression of advanced prostate cancer. Side effects resulting from these treatments include impotence, incontinence, fatigue, anemia, brittle bones, hair loss, reduced appetite, nausea and diarrhea. No toxic side effects were observed in the laboratory study of noscapine. MedInsight Research Institute

|
Advances in Drug Research, Volume 30
by Bernard Testa (Editor), Urs A. Meyer (Editor)
This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.
|

|
The Power of the Poppy: Harnessing Nature's Most Dangerous Plant Ally
by Kenaz Filan (Author)
A comprehensive look at the inspiring, healing, and addictive powers of the Opium Poppy and its derivatives throughout history • Covers the history, risks, and benefits of opium, morphine, oxycodone, methadone, and fentanyl • Provides techniques of cultivation, extraction, and safe consumption as well as methods for overcoming addiction and staying “clean” • Profiles 11 famous users, including Thomas de Quincey, William S. Burroughs, Lou Reed, and DJ Screw Few plant allies have a history as long and well-documented as Papaver somniferum, the celebrated and infamous opium poppy. For thousands of years people around the world have been unable to resist the poppy’s siren song of intoxicating pleasure, pain relief, and visionary...
|

|
Analysis of Addictive and Misused Drugs
by John A. Adamovics (Editor)
Examines the chromatographic and nonchromatographic methods available to identify, measure, and screen for nonmedical drug use, highlighting the latest technologies in immunochemical analysis, biosensors, thinlayer gas chromatography, high-performance liquid chromatography, and capillary electrophoresis. A comprehensive alphabetic listing of over 400 controlled-use drugs is provided.
|

|
Natural Remedies: Their Origins and Uses
by Finn Sandberg (Author), Desmond Corrigan (Author)
The past two decades have witnessed a phenomenal explosion of interest in the potential uses of plant medicines in healthcare and this has evoked the rebirth of pharmacognosy. This volume is unique in that it is the first, in English, to employ the Anatomical, Therapeutic and Chemical (ATC) classification system, developed by the World Health Organization, to present information on the therapeutic uses of plants. Initially developed in the Swedish edition 'Phytopharmaca Therapy', this volume expands the original concept and highlights the aspects of medicinal plants that are crucial for a comprehensive understanding of the role plant drugs can play in healthcare.
|

|
CHROMATOGRAPHY OF ALKALOIDS, PART B, Volume 23B: GAS-LIQUID CHROMATOGRAPHY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (Journal of Chromatography Library)
by Author Unknown (Editor)
The first of two books which provide an unparalleled reference source and handbook for everyone involved with alkaloid analyses. The first volume gives a comprehensive summary of the literature on thin layer chromatography of alkaloids. It presents the most effective methods for the separation and detection of alkaloids occurring in plant material, biological material, pharmaceutical preparations and drugs of abuse.
|

|
Capillary Electrophoresis Methods for Pharmaceutical Analysis
by George Lunn (Author)
Capillary Electrophoresis Techniques for Pharmaceutical Analysis at your fingertips-A complete, up-to-date library. This invaluable database--also available on CD-ROM--gives you fast, easy access to the growing literature on capillary electrophoresis (CE). Nearly 3,000 abstracts from approximately 900 publications make up this comprehensive library, listing CE techniques for the analysis of more than 700 active pharmaceutical compounds. From acarbose to mephobarbital to zopiclone--a number of procedures are grouped together for each compound. Detailed, precise information lets you replicate methods without referring to original articles as well as customize methods for specific needs. Features include: * Methods for drugs in biological fluids such as blood or urine as well as for...
|

|
Industrial Biotechnological Polymers
by Charles Gebelein (Author), Charles E. Carraher Jr. (Author)
From the Preface This book attempts to delineate some of the more recent efforts at utilizing biotechnology in industry. For convenience, this book is divided into the following five sections: (1) Industrial Applications, (2) Polysaccharides and Lignins, (3) Spider Silks, (4) Protein-Based Systems, and (5) Miscellaneous Biotechnological Polymers. The division is intended for the convenience of the reader and not to depict any basic demarcation in biotechnology, which already spans much of our modern technology and appears poised to embark on a course aimed at extending its boundaries even further. One of the newest trends in science is the mimicking of nature using solutions provided in nature (such as elasticity) to produce materials with distinctive properties. The papers in this...
|

|
Profiles of Drug Substances, Excipients and Related Methodology vol 11, Volume 11 (Analytical Profiles of Drug Substances & Excipients)
by Author Unknown (Editor)
|

|
HPLC Methods for Pharmaceutical Analysis
by George Lunn (Author), Norman R. Schmuff (Author)
Lets you target the specific information you need quickly and easily -so you can stay in the lab and out of the library. This invaluable database -available in print and electronic form -gives you fast, hands-on access to the most significant literature available on HPLC for the analysis of over 150 of the most frequently prescribed pharmaceutical compounds. Combining full descriptions of procedures with specially annotated references, HPLC Methods for Pharmaceutical Analysis helps you to identify the techniques that are relevant to your individual project needs -eliminating hours of tedious, time-consuming library research. Analytical chemists and researchers will find a battery of useful features that make this practical new resource a welcome addition to their reference library:...
|

|
The Analysis of Drugs of Abuse
by Terry A. Gough (Editor)
The Analysis of Drugs of Abuse Edited by Terry A. Gough, The Laboratory of the Government Chemist, Teddington, UK Analytical techniques based on separation processes, such as chromatography and electrophoresis, are finding a growing range of applications in chemical, biochemical and clinical laboratories: The aim of this series is to provide the analyst in these laboratories with well-focused books covering individual techniques and methods. This volume, devoted to the analysis of drugs which are commonly misused, provides a comprehensive source of up-to-date information. Detailed individual chapters are written by experts in the field describing various analytical techniques and applications. A special feature of the book is its emphasis on the complementary roles of chemist, law...
|
|